CUREVAC NV revenue breakdown overview

CUREVAC NV revenue for the last year amounted to 1.01 B MXN, the most of which — 987.15 M MXN — came from its highest performing source at the moment, Transformative Medicines Based on Messenger Ribonucleic Acid, the year earlier bringing 1.38 B MXN. The greatest contribution to the revenue figure was made by Belgium — last year it brought CUREVAC NV 865.41 M MXN, and the year before that — 1.28 B MXN.